Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Jan 27, 2024; 16(1): 1-5
Published online Jan 27, 2024. doi: 10.4240/wjgs.v16.i1.1
Published online Jan 27, 2024. doi: 10.4240/wjgs.v16.i1.1
Novel prognostic factors after radical resection of hepatocellular carcinoma: Updating an old issue
Lapo Bencini, Department of Oncology and Robotic Surgery, Careggi Main Florence University and Regional Hospital, Florence 50134, Italy
Author contributions: Bencini L ideated and completed the whole manuscript.
Conflict-of-interest statement: Lapo Bencini has nothing to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Lapo Bencini, PhD, Doctor, Senior Researcher, Surgeon, Department of Oncology and Robotic Surgery, Careggi Main Florence University and Regional Hospital, Largo Brambilla 3, Florence 50134, Italy. bencinil@aou-careggi.toscana.it
Received: October 29, 2023
Peer-review started: October 29, 2023
First decision: December 12, 2023
Revised: December 12, 2023
Accepted: January 8, 2024
Article in press: January 8, 2024
Published online: January 27, 2024
Processing time: 87 Days and 18.9 Hours
Peer-review started: October 29, 2023
First decision: December 12, 2023
Revised: December 12, 2023
Accepted: January 8, 2024
Article in press: January 8, 2024
Published online: January 27, 2024
Processing time: 87 Days and 18.9 Hours
Core Tip
Core Tip: Survival after radical surgery for liver cancer remain poor, with important perioperative complications and many organ recurrences. Prognostic scores have been developed and validated to select those patients who will best benefit from radical liver surgery, although the final general and oncological outcomes continue to be highly jeopardized. Some novel prognostic markers, including immune inflammatory and nutritional indexes could be of great help in better stratify surgical candidates.